{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T14:56:44Z","timestamp":1778770604236,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["971868"],"award-info":[{"award-number":["971868"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The pharmaceutical industry is continually striving to innovate drug development and formulation processes. Orally disintegrating tablets (ODTs) have gained popularity due to their quick release and patient-friendly characteristics. The choice of excipients in tablet formulations plays a critical role in ensuring product quality, highlighting its importance in tablet creation. The traditional trial-and-error approach to this process is both expensive and time-intensive. To tackle these obstacles, we introduce a fresh approach leveraging machine learning and deep learning methods to automate and enhance pre-formulation drug design.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We collected a comprehensive dataset of 1983 formulations, including excipient names, quantities, active ingredient details, and various physicochemical attributes. Our study focused on predicting two critical control test parameters: tablet disintegration time and hardness. We compared a range of models like deep learning, artificial neural networks, support vector machines, decision trees, multiple linear regression, and random forests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A 12-layer deep neural network, as a form of deep learning, surpassed alternative techniques by achieving 73% accuracy for disintegration time and 99% for tablet hardness. This success underscores its efficacy in predicting complex pharmaceutical factors. Such an approach streamlines the drug formulation process, reducing iterations and material consumption.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings highlight the deep learning potential in pharmaceutical formulations, particularly for tablet hardness prediction. Future work should focus on enlarging the dataset to improve model effectiveness and extend its application in pharmaceutical product development and assessment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12911-024-02485-4","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:02:14Z","timestamp":1711533734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests"],"prefix":"10.1186","volume":"24","author":[{"given":"Mehri","family":"Momeni","sequence":"first","affiliation":[]},{"given":"Marziyeh","family":"Afkanpour","sequence":"additional","affiliation":[]},{"given":"Saleh","family":"Rakhshani","sequence":"additional","affiliation":[]},{"given":"Amin","family":"Mehrabian","sequence":"additional","affiliation":[]},{"given":"Hamed","family":"Tabesh","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"issue":"1","key":"2485_CR1","first-page":"163","volume":"1","author":"D Bhowmik","year":"2009","unstructured":"Bhowmik D, Chiranjib B, Krishnakanth P, Chandira RM. Fast dissolving tablet: an overview. J Chem Pharm Res. 2009;1(1):163\u201377.","journal-title":"J Chem Pharm Res"},{"issue":"5","key":"2485_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1081\/DDC-120037483","volume":"30","author":"M Valleri","year":"2004","unstructured":"Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm. 2004;30(5):525\u201334.","journal-title":"Drug Dev Ind Pharm"},{"key":"2485_CR3","unstructured":"Allen L, Ansel HC. Ansel\u2019s pharmaceutical dosage forms and drug delivery systems. Lippincott Williams & Wilkins; 2013."},{"key":"2485_CR4","first-page":"131","volume":"1","author":"FJ Bandelin","year":"1989","unstructured":"Bandelin FJ. Compressed tablets by wet granulation. Pharm Dosage Forms: Tablets. 1989;1:131\u201393.","journal-title":"Pharm Dosage Forms: Tablets"},{"key":"2485_CR5","unstructured":"Dash A, Singh S. Pharmaceutics: basic principles and application to pharmacy practice. Academic; 2013."},{"key":"2485_CR6","unstructured":"Felton LA. Essentials of pharmaceutics2012."},{"key":"2485_CR7","doi-asserted-by":"crossref","unstructured":"Moreton RC. Disintegrants in tableting. Pharmaceutical dosage forms-tablets. CRC; 2008. pp. 233\u201366.","DOI":"10.3109\/9781420020298-10"},{"issue":"4","key":"2485_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s11095-007-9511-1","volume":"25","author":"XY Lawrence","year":"2008","unstructured":"Lawrence XY. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25(4):781\u201391.","journal-title":"Pharm Res"},{"issue":"4","key":"2485_CR9","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","volume":"16","author":"XY Lawrence","year":"2014","unstructured":"Lawrence XY, Amidon G, Khan MA, Hoag SW, Polli J, Raju G, et al. Understanding pharmaceutical quality by design. AAPS J. 2014;16(4):771\u201383.","journal-title":"AAPS J"},{"issue":"7","key":"2485_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/pharmaceutics12070601","volume":"12","author":"Y Hayashi","year":"2020","unstructured":"Hayashi Y, Shirotori K, Kosugi A, Kumada S, Leong KH, Okada K, et al. A precise prediction method for the properties of API-containing tablets based on data from placebo tablets. Pharmaceutics. 2020;12(7):601.","journal-title":"Pharmaceutics"},{"issue":"3","key":"2485_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ejpb.2006.06.008","volume":"64","author":"P P\u00e9rez","year":"2006","unstructured":"P\u00e9rez P, Su\u00f1\u00e9-Negre JM, Mi\u00f1arro M, Roig M, Fuster R, Garc\u00eda-Montoya E, et al. A new expert systems (SeDeM Diagram) for control batch powder formulation and preformulation drug products. Eur J Pharm Biopharm. 2006;64(3):351\u20139.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"2485_CR12","first-page":"179","volume":"1","author":"K Saroha","year":"2010","unstructured":"Saroha K, Mathur P, Verma S, Syan N, Kumar A. Mouth dissolving tablets: an overview on future compaction in oral formulation technologies. Der Pharmacia Sinica. 2010;1(1):179\u201387.","journal-title":"Der Pharmacia Sinica"},{"key":"2485_CR13","doi-asserted-by":"crossref","unstructured":"Sharma D. Formulation development and evaluation of fast disintegrating tablets of salbutamol sulphate for respiratory disorders. ISRN pharmaceutics. 2013;2013.","DOI":"10.1155\/2013\/674507"},{"issue":"4","key":"2485_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajps.2018.01.003","volume":"13","author":"R Han","year":"2018","unstructured":"Han R, Yang Y, Li X, Ouyang D. Predicting oral disintegrating tablet formulations by neural network techniques. Asian J Pharm Sci. 2018;13(4):336\u201342.","journal-title":"Asian J Pharm Sci"},{"key":"2485_CR15","first-page":"137","volume-title":"New SeDeM-ODT expert system: an expert system for formulation of orodispersible tablets obtained by direct compression","author":"JE Aguilar","year":"2013","unstructured":"Aguilar JE, Montoya EG, Lozano PP, Negre JMS, Carmona MM, Grau JRT. New SeDeM-ODT expert system: an expert system for formulation of orodispersible tablets obtained by direct compression. Formulation tools for pharmaceutical development: Elsevier; 2013. pp. 137\u201354."},{"issue":"3","key":"2485_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ejpb.2011.12.012","volume":"80","author":"JE Aguilar-D\u00edaz","year":"2012","unstructured":"Aguilar-D\u00edaz JE, Garc\u00eda-Montoya E, Su\u00f1e-Negre JM, P\u00e9rez-Lozano P, Mi\u00f1arro M, Tic\u00f3 JR. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system. Eur J Pharm Biopharm. 2012;80(3):638\u201348.","journal-title":"Eur J Pharm Biopharm"},{"key":"2485_CR17","first-page":"203","volume-title":"Oxpirt: ontology-based expert system for production of a generic immediate release tablet","author":"N Chalortham","year":"2013","unstructured":"Chalortham N, Ruangrajitpakorn T, Supnithi T, Leesawat P. Oxpirt: ontology-based expert system for production of a generic immediate release tablet. Formulation tools for pharmaceutical development: Elsevier; 2013. pp. 203\u201328."},{"key":"2485_CR18","first-page":"39","volume-title":"ME_expert 2.0: a heuristic decision support system for microemulsions formulation development","author":"A Mendyk","year":"2013","unstructured":"Mendyk A, Szlek J, Jachowicz R. ME_expert 2.0: a heuristic decision support system for microemulsions formulation development. Formulation tools for pharmaceutical development: Elsevier; 2013. pp. 39\u201371."},{"issue":"2","key":"2485_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ijpharm.2011.03.065","volume":"418","author":"A Merzlikine","year":"2011","unstructured":"Merzlikine A, Abramov YA, Kowsz SJ, Thomas VH, Mano T. Development of machine learning models of \u03b2-cyclodextrin and sulfobutylether-\u03b2-cyclodextrin complexation free energies. Int J Pharm. 2011;418(2):207\u201316.","journal-title":"Int J Pharm"},{"issue":"4","key":"2485_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1461-5347(98)00042-X","volume":"1","author":"RC Rowe","year":"1998","unstructured":"Rowe RC, Roberts RJ. Artificial intelligence in pharmaceutical product formulation: knowledge-based and expert systems. Pharm Sci Technol Today. 1998;1(4):153\u20139.","journal-title":"Pharm Sci Technol Today"},{"issue":"12","key":"2485_CR21","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1002\/jps.23745","volume":"102","author":"H Trnka","year":"2013","unstructured":"Trnka H, Wu JX, Van De Weert M, Grohganz H, Rantanen J. Fuzzy logic-based expert system for evaluating cake quality of freeze-dried formulations. J Pharm Sci. 2013;102(12):4364\u201374.","journal-title":"J Pharm Sci"},{"key":"2485_CR22","doi-asserted-by":"publisher","first-page":"E449","DOI":"10.1208\/pt060356","volume":"6","author":"WI Wilson","year":"2005","unstructured":"Wilson WI, Peng Y, Augsburger LL. Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development. AAPS PharmSciTech. 2005;6:E449\u201357.","journal-title":"AAPS PharmSciTech"},{"key":"2485_CR23","first-page":"73","volume-title":"Expert system for the development and formulation of push\u2013pull osmotic pump tablets containing poorly water-soluble drugs","author":"Z-h Zhang","year":"2013","unstructured":"Zhang Z-h. Expert system for the development and formulation of push\u2013pull osmotic pump tablets containing poorly water-soluble drugs. Formulation tools for pharmaceutical development: Elsevier; 2013. pp. 73\u2013108."},{"issue":"4","key":"2485_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1021\/acscentsci.6b00367","volume":"3","author":"H Altae-Tran","year":"2017","unstructured":"Altae-Tran H, Ramsundar B, Pappu AS, Pande V. Low data drug discovery with one-shot learning. ACS Cent Sci. 2017;3(4):283\u201393.","journal-title":"ACS Cent Sci"},{"issue":"11","key":"2485_CR25","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1007\/s11095-016-2029-7","volume":"33","author":"S Ekins","year":"2016","unstructured":"Ekins S. The next era: deep learning in pharmaceutical research. Pharm Res. 2016;33(11):2594\u2013603.","journal-title":"Pharm Res"},{"issue":"7","key":"2485_CR26","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1021\/ci400187y","volume":"53","author":"A Lusci","year":"2013","unstructured":"Lusci A, Pollastri G, Baldi P. Deep architectures and deep learning in chemoinformatics: the prediction of aqueous solubility for drug-like molecules. J Chem Inf Model. 2013;53(7):1563\u201375.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"2485_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1021\/ci500747n","volume":"55","author":"J Ma","year":"2015","unstructured":"Ma J, Sheridan RP, Liaw A, Dahl GE, Svetnik V. Deep neural nets as a method for quantitative structure\u2013activity relationships. J Chem Inf Model. 2015;55(2):263\u201374.","journal-title":"J Chem Inf Model"},{"issue":"1","key":"2485_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.apsb.2018.09.010","volume":"9","author":"Y Yang","year":"2019","unstructured":"Yang Y, Ye Z, Su Y, Zhao Q, Li X, Ouyang D. Deep learning for in vitro prediction of pharmaceutical formulations. Acta Pharm Sinica B. 2019;9(1):177\u201385.","journal-title":"Acta Pharm Sinica B"},{"issue":"1","key":"2485_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-023-06416-w","volume":"16","author":"M Momeni","year":"2023","unstructured":"Momeni M, Rakhshani S, Abbaspour M, Alizadeh F, Sheikhi N, GhorbanZadeh F, et al. Dataset development of pre-formulation tests on fast disintegrating tablets (FDT): data aggregation. BMC Res Notes. 2023;16(1):1\u20135.","journal-title":"BMC Res Notes"},{"issue":"1","key":"2485_CR30","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.xphs.2016.08.026","volume":"106","author":"I Akseli","year":"2017","unstructured":"Akseli I, Xie J, Schultz L, Ladyzhynsky N, Bramante T, He X, et al. A practical framework toward prediction of breaking force and disintegration of tablet formulations using machine learning tools. J Pharm Sci. 2017;106(1):234\u201347.","journal-title":"J Pharm Sci"},{"key":"2485_CR31","unstructured":"Mueller JP, Massaron L. Deep learning for dummies. Wiley; 2019."},{"issue":"1","key":"2485_CR32","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ijpharm.2017.08.111","volume":"532","author":"Y Hayashi","year":"2017","unstructured":"Hayashi Y, Tsuji T, Shirotori K, Oishi T, Kosugi A, Kumada S, et al. Relationships between response surfaces for tablet characteristics of placebo and API-containing tablets manufactured by direct compression method. Int J Pharm. 2017;532(1):82\u20139.","journal-title":"Int J Pharm"},{"key":"2485_CR33","doi-asserted-by":"crossref","unstructured":"Li G, Zhao B, Su X, Yang Y, Hu P, Zhou X et al. Discovering consensus regions for interpretable identification of RNA N6-methyladenosine modification sites via graph contrastive clustering. IEEE J Biomedical Health Inf. 2024.","DOI":"10.1109\/JBHI.2024.3357979"},{"issue":"9","key":"2485_CR34","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1109\/TFUZZ.2021.3117442","volume":"30","author":"L Hu","year":"2021","unstructured":"Hu L, Pan X, Tang Z, Luo X. A fast fuzzy clustering algorithm for complex networks via a generalized momentum method. IEEE Trans Fuzzy Syst. 2021;30(9):3473\u201385.","journal-title":"IEEE Trans Fuzzy Syst"},{"key":"2485_CR35","unstructured":"pre-formulation tests on fast disintegrating tablets(FDT) [Internet]. Harvard Dataverse. 2023. Available from: https:\/\/doi.org\/10.7910\/DVN\/TUSJYB."}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-024-02485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:05:48Z","timestamp":1711533948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-024-02485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1186\/s12911-024-02485-4","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was assessed by the research council of Mashhad University of Medical Sciences (Reference Number: IR.MUMS.MEDICAL.REC.1398.256). The study was approved because no identifying data have been reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}